| Date Filed | Type | Description |
| 05/02/2019 |
4
| KLEMA CATHY (Director) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 953 shares
@ $147, valued at
$140.1k
|
|
| 03/13/2019 |
4
| KLEMA CATHY (Director) has filed a Form 4 on Allergan plc|
Txns:
| Acquired 410 shares
@ $0 |
|
| 05/04/2018 |
4
| KLEMA CATHY (Director) has filed a Form 4 on Allergan plc|
Txns:
| Granted 1,985 shares
@ $151.07, valued at
$299.9k
|
|
| 05/05/2017 |
4
| KLEMA CATHY (Director) has filed a Form 4 on Allergan plc |
| 08/09/2016 |
4
| KLEMA CATHY (Director) has filed a Form 4 on Allergan plc |
| 05/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/30/2015 |
4/A
| KLEMA CATHY (Director) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 549 shares
@ $303.38, valued at
$166.6k
Granted 826 shares
@ $302.3, valued at
$249.7k
|
|
| 06/08/2015 |
4
| KLEMA CATHY (Director) has filed a Form 4 on Actavis plc|
Txns:
| Paid exercise price by delivering 549 shares
@ $303.38, valued at
$166.6k
Granted 826 shares
@ $302.3, valued at
$249.7k
|
|
| 05/13/2014 |
4
| KLEMA CATHY (Director) has filed a Form 4 on Actavis plc|
Txns:
| Granted 1,142 shares
@ $197.05, valued at
$225k
|
|
| 10/03/2013 |
4
| KLEMA CATHY (Director) has filed a Form 4 on Actavis plc|
Txns:
| Granted 19,608 shares
@ $0 |
|
| 10/03/2013 |
3
| KLEMA CATHY (Director) has filed a Form 3 on Actavis plc |
| 10/02/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/14/2013 |
4
| KLEMA CATHY (Director) has filed a Form 4 on Actavis, Inc.|
Txns:
| Gifted 5,000 shares
@ $0
Gifted 3,334 shares
@ $0
Sold 1,667 shares
@ $133.0333, valued at
$221.8k
|
|
| 08/01/2012 |
4
| KLEMA CATHY (Director) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 11,700 shares
@ $78.38, valued at
$917k
Sold 5,000 shares
@ $78.38, valued at
$391.9k
Exercised 11,700 options to buy
@ $44.14, valued at
$516.4k
Exercised 5,000 options to buy
@ $30.12, valued at
$150.6k
Exercised 5,000 options to buy
@ $29.03, valued at
$145.2k
|
|
| 05/14/2012 |
4
| KLEMA CATHY (Director) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 2,887 shares
@ $0 |
|
| 05/17/2011 |
4
| KLEMA CATHY (Director) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 3,177 shares
@ $0 |
|
| 01/04/2011 |
4
| KLEMA CATHY (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Granted 2,355 shares
@ $0 |
|
| 08/02/2010 |
4
| KLEMA CATHY (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Granted 9,090 options to buy
@ $24.26, valued at
$220.5k
|
|
| 05/21/2010 |
4
| KLEMA CATHY (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC|
Txns:
| Granted 10,140 options to buy
@ $25.38, valued at
$257.4k
|
|
| 05/11/2010 |
4
| KLEMA CATHY (Director) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 5,000 shares
@ $0 |
|
| 01/05/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/22/2009 |
4
| KLEMA CATHY (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC |
| 05/11/2009 |
4
| KLEMA CATHY (Director) has filed a Form 4 on WATSON PHARMACEUTICALS INC |
| 01/05/2009 |
4
| KLEMA CATHY (Director) has filed a Form 4 on PHARMACEUTICAL PRODUCT DEVELOPMENT INC |